These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16462975)

  • 1. Polypill holds promise for people with chronic disease.
    Wise J
    Bull World Health Organ; 2005 Dec; 83(12):885-7. PubMed ID: 16462975
    [No Abstract]   [Full Text] [Related]  

  • 2. "Polypill-aspostatinoprilololazide folate"--coprescription for at the risk Asian Indian in chronic non communicable diseases.
    Joshi SR
    J Assoc Physicians India; 2005 Mar; 53():175-8. PubMed ID: 15926597
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus].
    Ruiz J; Egli M
    Rev Med Suisse; 2006 May; 2(68):1480-2, 1484-5. PubMed ID: 16783994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypill in cardiovascular disease: has it's time come?
    Kuppuswamy V; Choo WK; Gupta S
    Indian Heart J; 2009; 61(4):322-7. PubMed ID: 20635733
    [No Abstract]   [Full Text] [Related]  

  • 5. Physician support for a population-based pharmaceutical approach to cardiovascular prevention: not there yet.
    Huy C; Litaker D
    Prev Med; 2011 Jan; 52(1):18-9. PubMed ID: 21130110
    [No Abstract]   [Full Text] [Related]  

  • 6. [The polypill: optimal strategy for reduction of cardiovascular disease].
    Nathoe HM; Doevendans PA
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1740. PubMed ID: 16114290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating many conditions--with just one pill. The polypill could make your medicines much easier to take.
    Harv Womens Health Watch; 2012 Dec; 20(4):5. PubMed ID: 23346615
    [No Abstract]   [Full Text] [Related]  

  • 8. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 9. [The polypill: not an effective strategy for reduction of cardiovascular disease].
    Westerweel PE; van Wijk JP; Verhaar MC
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1741. PubMed ID: 16114291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?
    Stirban AO; Tschoepe D
    Diabetes Care; 2008 Feb; 31 Suppl 2():S226-8. PubMed ID: 18227490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The polypill as cardiovascular prophylactic: clinical trials].
    Sandli OK; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2014 Mar; 134(6):620-3. PubMed ID: 24670510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe.
    Thom S; Field J; Poulter N; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Rodgers A
    Eur J Prev Cardiol; 2014 Feb; 21(2):252-61. PubMed ID: 23038750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 14. [The Polypill - A Practicable Approach?].
    Thürmann PA; Kleinerüschkamp AG; Boehme P
    Dtsch Med Wochenschr; 2019 Jun; 144(11):715-718. PubMed ID: 31163467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could the polypill improve adherence? The patient perspective.
    Bryant L; Martini N; Chan J; Chang L; Marmoush A; Robinson B; Yu K; Wong M
    J Prim Health Care; 2013 Mar; 5(1):28-35. PubMed ID: 23457692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Meggison H
    Clin Evid; 2004 Jun; (11):777-806. PubMed ID: 15652037
    [No Abstract]   [Full Text] [Related]  

  • 17. Canadian Hypertension Education Program. Brief overview of 2004 recommendations.
    Campbell N;
    Can Fam Physician; 2004 Oct; 50():1411-5. PubMed ID: 15526879
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Arnaout A
    Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert.
    Green LW
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S4-8; discussion S9. PubMed ID: 16052194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polypill to prevent cardiovascular disease: physicians' perspectives.
    Viera AJ
    Curr Opin Cardiol; 2011 Sep; 26(5):438-42. PubMed ID: 21730826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.